Prestige Consumer Healthcare (PBH) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Prestige Consumer Healthcare insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $424K of PBH stock on the open market.
Get emailed when insiders cluster-buy stocks like PBH
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PBH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $120K | 4 |
| Q1 2026 | — | 0 | $66K | 1 |
| Q4 2025 | — | 0 | $238K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Prestige Consumer Healthcare Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $424K. 5 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 12SEC | Jeffrey ZerilloSenior Vp Operations | Sell Plan | 35141,810 held (−1%) | $52.28 | $18K | -7.7% | — |
| May 11SEC | Jeffrey ZerilloSenior Vp Operations | Sell Plan | 30542,161 held (−1%) | $54.36 | $17K | -11.3% | — |
| May 7SEC | Jeffrey ZerilloSenior Vp Operations | Sell | 1,20742,820 held (−3%) | $54.99 | $66K | -12.3% | — |
| May 6SEC | Jeffrey ZerilloSenior Vp Operations | Sell Plan | 34644,334 held (−1%) | $55.32 | $19K | -12.8% | — |
| Feb 13SEC | Jeffrey ZerilloSenior Vp Operations | Sell | 1,00041,048 held (−2%) | $65.93 | $66K | -26.8% | — |
| Dec 2SEC | Jeffrey ZerilloSenior Vp Operations | Sell Plan | 71942,329 held (−2%) | $60.00 | $43K | -19.6% | — |
| Dec 2SEC | Jeffrey ZerilloSenior Vp Operations | Sell Plan | 28142,048 held (−1%) | $60.00 | $17K | -19.6% | — |
| Nov 26SEC | John E ByomDirector | Sell | 3,00051,594 held (−5%) | $59.35 | $178K | -18.7% | — |
Insiders at Prestige Consumer Healthcare Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Jeffrey ZerilloSenior Vp Operations | — | $246K | May 12, 2026 | — |
| John E ByomDirector | — | $178K | Nov 26, 2025 | — |
PBH stock: common questions
Are Prestige Consumer Healthcare Inc. insiders buying PBH stock?
In the past 12 months, 0 insiders reported open-market purchases of PBH worth $0.
Are Prestige Consumer Healthcare Inc. insiders selling PBH stock?
2 insiders reported sales worth $424K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PBH's 52-week range?
Over the past year PBH has traded between $44.77 and $70.21. It last closed at $48.23 on Oct 9, 2026.